|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng X, Sun P, Hu QG, Song ZF, Xiong J
and Zheng QC: Transarterial (chemo)embolization for curative
resection of hepatocellular carcinoma: A systematic review and
meta-analyses. J Cancer Res Clin Oncol. 140:1159–1170. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen JF, Mandel EM, Thomson JM, Wu Q,
Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Xiao Y, Ge W, Zhou K, Wen J, Yan
W, Wang Y, Wang B, Qu C, Wu J, et al: miR-200b inhibits
TGF-β1-induced epithelial-mesenchymal transition and promotes
growth of intestinal epithelial cells. Cell Death Dis. 4:e5412013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schetter AJ and Harris CC: Alterations of
microRNAs contribute to colon carcinogenesis. Semin Oncol.
38:734–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Slaby O, Svoboda M, Michalek J and Vyzula
R: MicroRNAs in colorectal cancer: Translation of molecular biology
into clinical application. Mol Cancer. 8:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Chu F, Cao Y, Shao J and Wang F:
Serum miR-182 and miR-331-3p as diagnostic and prognostic markers
in patients with hepatocellular carcinoma. Tumour Biol.
36:7439–7447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang D, Tan J, Xu Y, Tan X, Han M, Tu Y,
Zhu Z, Zen J, Dou C and Cai S: Identification of MicroRNAs and
target genes involvement in hepatocellular carcinoma with
microarray data. Hepatogastroenterology. 62:378–382.
2015.PubMed/NCBI
|
|
13
|
Wong CM, Wei L, Au SL, Fan DN, Zhou Y,
Tsang FH, Law CT, Lee JM, He X, Shi J, et al: MiR-200b/200c/429
subfamily negatively regulates Rho/ROCK signaling pathway to
suppress hepatocellular carcinoma metastasis. Oncotarget.
6:13658–13670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen Y, Han J, Chen J, Dong J, Xia Y, Liu
J, Jiang Y, Dai J, Lu J, Jin G, et al: Plasma miRNAs as early
biomarkers for detecting hepatocellular carcinoma. Int J Cancer.
137:1679–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sepramaniam S, Armugam A, Lim KY, Karolina
DS, Swaminathan P, Tan JR and Jeyaseelan K: MicroRNA 320a functions
as a novel endogenous modulator of aquaporins 1 and 4 as well as a
potential therapeutic target in cerebral ischemia. J Biol Chem.
285:29223–29230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao J, Liang LH, Zhang Y, Ding J, Tian Q,
Li JJ and He XH: GNAI1 suppresses tumor cell migration and invasion
and is post-transcriptionally regulated by Mir-320a/c/d in
hepatocellular carcinoma. Cancer Biol Med. 9:234–241.
2012.PubMed/NCBI
|
|
17
|
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P,
Zhang Q, Dong L, Liu Y and Dong J: microRNA-320a inhibits tumor
invasion by targeting neuropilin 1 and is associated with liver
metastasis in colorectal cancer. Oncol Rep. 27:685–694.
2012.PubMed/NCBI
|
|
18
|
Zhao H, Dong T, Zhou H, Wang L, Huang A,
Feng B, Quan Y, Jin R, Zhang W, Sun J, et al: miR-320a suppresses
colorectal cancer progression by targeting Rac1. Carcinogenesis.
35:886–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun JY, Huang Y, Li JP, Zhang X, Wang L,
Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, et al: MicroRNA-320a
suppresses human colon cancer cell proliferation by directly
targeting beta-catenin. Biochem Biophys Res Commun. 420:787–792.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng Z, Qiu S, Jiang L, Zhang A, Bao W,
Liu P and Liu J: MiR-320a is downregulated in patients with
myasthenia gravis and modulates inflammatory cytokines production
by targeting mitogen-activated protein kinase 1. J Clin Immunol.
33:567–576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sorensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-Catenin activates MiR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Zhou R, Yuan X, Han N, Zhou S, Xu
H, Guo M, Yu S, Zhang C, Yin T and Wu K: DACH1 is a novel
predictive and prognostic biomarker in hepatocellular carcinoma as
a negative regulator of Wnt/β-catenin signaling. Oncotarget.
6:8621–8634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mok M and Cheng AS: CUL4B: A novel
epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis.
J Pathol. 236:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao
J, Liu B, Liu J, Chen N, Li M and Zhu R: Notch3 functions as a
regulator of cell self-renewal by interacting with the β-catenin
pathway in hepatocellular carcinoma. Oncotarget. 6:3669–3679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fatima S, Lee NP and Luk JM: Dickkopfs and
Wnt/β-catenin signalling in liver cancer. World J Clin Oncol.
2:311–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prange W, Breuhahn K, Fischer F, Zilkens
C, Pietsch T, Petmecky K, Eilers R, Dienes HP and Schirmacher P:
Beta-catenin accumulation in the progression of human
hepatocarcinogenesis correlates with loss of E-cadherin and
accumulation of p53, but not with expression of conventional WNT-1
target genes. J Pathol. 201:250–259. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwack MH, Hwang SY, Jang IS, Im SU, Kim
JO, Kim MK, Kim JC and Sung YK: Analysis of cellular changes
resulting from forced expression of Dickkopf-1 in hepatocellular
carcinoma cells. Cancer Res Treat. 39:30–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang L, He H, Lv R, Zhang M, Huang H, An
Z and Li S: Preliminary mechanism on the methylation modification
of Dkk-1 and Dkk-3 in hepatocellular carcinoma. Tumour Biol.
36:1245–1250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qin X, Zhang H, Zhou X, Wang C, Zhang H,
Zhang X and Ye L: Proliferation and migration mediated by
Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular
carcinoma cells. Transl Res. 150:281–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirata H, Hinoda Y, Ueno K, Nakajima K,
Ishii N and Dahiya R: MicroRNA-1826 directly targets beta-catenin
(CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
Carcinogenesis. 33:501–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Veronese A, Visone R, Consiglio J, Acunzo
M, Lupini L, Kim T, Ferracin M, Lovat F, Miotto E, Balatti V, et
al: Mutated beta-catenin evades a microRNA-dependent regulatory
loop. Proc Natl Acad Sci USA. 108:4840–4845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia H, Cheung WK, Sze J, Lu G, Jiang S,
Yao H, Bian XW, Poon WS, Kung HF and Lin MC: miR-200a regulates
epithelial-mesenchymal to stem-like transition via ZEB2 and
beta-catenin signaling. J Biol Chem. 285:36995–37004. 2010.
View Article : Google Scholar : PubMed/NCBI
|
